Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Clinical trial NCT07563881 · RECRUITING
Trial details
- NCT number
- NCT07563881
- Sponsor
- Rapport Therapeutics Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-05
- Primary completion
- 2029-07-01
- Enrollment
- 333
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.